Treatment of Nasal Airway Obstruction Using the Aerin Medical Device

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

September 27, 2016

Primary Completion Date

July 21, 2017

Study Completion Date

August 18, 2017

Conditions
Nasal Obstruction
Interventions
DEVICE

Vivaer Stylus

Delivery of low-power, temperature-controlled, radiofrequency energy to the tissues of the internal nasal valve area

Trial Locations (9)

10017

ENT and Allergy Associates, LLP, New York

10314

ENT and Allergy Associates, LLP, Staten Island

11042

ENT and Allergy Associates, LLP, New Hyde Park

11360

ENT and Allergy Associates, LLP, Bayside

27103

Piedmont Ear, Nose and Throat Associates, Winston-Salem

75070

Ear, Nose and Throat Associates of Texas, McKinney

80909

Colorado ENT and Allergy, Colorado Springs

93720

Central California Clinical Research, Fresno

07649

ENT and Allergy Associates, LLP, Oradell

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Aerin Medical

INDUSTRY

NCT02914236 - Treatment of Nasal Airway Obstruction Using the Aerin Medical Device | Biotech Hunter | Biotech Hunter